William Blair Downgrades Pharmasset (VRUS) to Market Perform
Tweet
Share
E-mailGet Alerts VRUS Hot Sheet
Price: $0.00 --0%
Rating Summary:
3 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
3 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
William Blair downgraded Pharmasset (NASDAQ: VRUS) from Outperform to Market Perform, price target raised from $108 to $137.
For an analyst ratings summary and ratings history on Pharmasset click here. For more ratings news on Pharmasset click here.
Shares of Pharmasset closed at $134.14 yesterday.
For an analyst ratings summary and ratings history on Pharmasset click here. For more ratings news on Pharmasset click here.
Shares of Pharmasset closed at $134.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
- William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
- CLSA Downgrades Mphasis Ltd. (MPHL:IN) to Underperform (4)
Create E-mail Alert Related Categories
DowngradesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
